Clinical Characteristics and Predictive Factors of Subclinical Diabetic Nephropathy

Y. Zhang; J. Yang; M. Zheng; Y. Wang; H. Ren; Y. Xu; Y. Yang; J. Cheng; F. Han; X. Yang; L. Chen; C. Shan; B. Chang

doi:10.1055/s-0034-1396810

Experimental and Clinical Endocrinology & Diabetes, Inhaltsverzeichnis

Exp Clin Endocrinol Diabetes 2015; 123(02): 132-138
DOI: 10.1055/s-0034-1396810

Article

Clinical Characteristics and Predictive Factors of Subclinical Diabetic Nephropathy

Y. Zhang^*

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

J. Yang^*

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

M. Zheng

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

Y. Wang

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

H. Ren

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

Y. Xu

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

Y. Yang

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

J. Cheng

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

F. Han

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

X. Yang

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

L. Chen

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

C. Shan

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

,

B. Chang

¹Department of Nephropathy, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, the Key Laboratory of Hormones and Development (Ministry of Health), Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China

› Institutsangaben

Abstract

Background: To investigate the clinical characteristics and predictive factors of subclinical diabetic nephropathy in type 2 diabetes patients.

Methods: A total of 298 type 2 diabetes patients were divided into 3 groups based on 24-h urinary microalbumin and estimated glomerular filtration rate: patients with normal albuminuria and glomerular filtration rate (NC), patients with normoalbuminuria and glomerular hyperfiltration (SDN) and patients with microalbuminuria (EDN). The renal size, tubular injury markers and ambulatory blood pressure were analyzed.

Results: Renal size increased in the SDN and EDN groups compared to the NC group (P<0.05), while renal length in the SDN group was greater than the EDN group (P<0.05). Patients in the SDN and EDN groups had higher level of urine retinol binding protein and N-acetyl-β-D-glucosaminidase and most of them developed proximal tubular dysfunction. The SDN group had higher 24-h mean and nocturnal diastolic blood pressure than the NC group (P<0.05), while the EDN group had higher systolic blood pressure and pulse pressure than the SDN group (P<0.01). More patients developed abnormal blood pressure rhythm in the SDN and EDN groups. The likelihood of a decrease in nocturnal systolic blood pressure was lower as the microalbuminuria increased. Increased renal size, more abnormal tubular injury markers and higher 24-h mean and nocturnal blood pressure were all risk factors of subclinical diabetic nephropathy.

Conclusion: Patients with subclinical diabetic nephropathy had increased renal size, abnormal tubular injury markers, high blood pressure and abnormal circadian rhythm.

Key words

ambulatory blood pressure - diabetic nephropathy - glomerular filtration rate - microalbuminuria - renal tubular injury markers

Volltext

Referenzen

References
1 Menon R, Mohd Noor FS, Draman CR et al. A retrospective review of diabetic nephropathy patients during referral to the sub-urban nephrology clinic. Saudi J Kidney Dis Transpl 2012; 23: 1109-1114
2 Fioretto P, Caramori ML, Mauer M. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. Diabetologia 2008; 51: 1347-1355
3 Liu C, Chen H, Liu C et al. Combined application of eGFR and albuminuria for the precise diagnosis of stage 2 and 3a CKD in the elderly. J Nephrol 2014; 27: 289-297
4 Afsar B, Elsurer R. The independent relationship between creatinine clearance, microalbuminuria and circadian blood pressure levels in newly diagnosed essential hypertensive and type 2 diabetic patients. J Diabetes Complications 2012; 26: 531-535
5 Jennersjo PE, Wijkman M, Wirehn AB et al. Circadian blood pressure variation in patients with type 2 diabetes – relationship to macro- and microvascular subclinical organ damage. Prim Care Diabetes 2011; 5: 167-173
6 Leoncini G, Ratto E, Viazzi F et al. The role of microalbuminuria in the overall risk assessment of hypertensive patients. G Ital Nefrol 2007; 24: 565-573
7 National Kidney Foundation . K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
8 Buchholz NP, Abbas F, Biyabani SR et al. Ultrasonographic renal size in individuals without known renal disease. J Pak Med Assoc 2000; 50: 12-16
9 Morrisey K, Steadman R, Williams JD et al. Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent. Kidney Int 1999; 55: 2548-2572
10 Phillips AO, Morrisey K, Steadman R et al. Decreased degradation of collagen and fibronectin following exposure of proximal cells to glucose. Exp Nephrol 1999; 7: 449-462
11 Rigalleau V, Garcia M, Lasseur C et al. Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease. BMC Nephrol 2010; 11: 3
12 Nosadini R, Velussi M, Brocco E et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 2000; 49: 476-484
13 Fu WJ, Xiong SL, Fang YG et al. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 2012; 41: 82-88
14 Fu WJ, Li BL, Wang SB et al. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res Clin Pract 2012; 95: 105-109
15 Bonventre JV. Can we target tubular damage to prevent renal function decline in diabetes?. Semin Nephrol 2012; 32: 452-462
16 Bakris GL, Weir MR, Shanifar S et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003; 163: 1555-1565
17 Cirillo M, Stellato D, Laurenzi M et al. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group. Kidney Int 2000; 58: 1211-1218
18 Guo X, Lu X, Yang J et al. Increased aortic stiffness elevates pulse and mean pressure and compromises endothelial function in Wistar rats. Am J Physiol Heart Circ Physiol 2014; 307: H880-H887
19 Schmieder RE, Schutte R, Schumacher H et al. Mortality and morbidity in relation to changes in albuminuria, glucose status and systolic blood pressure: an analysis of the ONTARGET and TRANSCEND studies. Diabetologia 2014; 57: 2019-2029
20 Izzedine H, Launay-Vacher V, Deray G. Abnormal blood pressure circadian rhythm: a target organ damage?. Int J Cardiol 2006; 107: 343-349
21 Palmas W, Pickering T, Teresi J et al. Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes. J Clin Hypertens (Greenwich) 2008; 10: 12-20
22 Nielsen FS, Rossing P, Bang LE et al. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995; 44: 783-789
23 Jerums G, Panagiotopoulos S, Premaratne E et al. Integrating albuminuria and GFR in the assessment of diabetic nephropathy. Nat Rev Nephrol 2009; 5: 397-406
24 Philips JC, Marchand M, Scheen AJ. Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes. Diabetes Metab Res Rev 2009; 25: 442-451
25 Sachdeva A, Weder AB. Nocturnal sodium excretion, blood pressure dipping, and sodium sensitivity. Hypertension 2006; 48: 527-533
26 Jerums G, Premaratne E, Panagiotopoulos S et al. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010; 53: 2093-2104
27 Palmas W, Pickering T, Eimicke JP et al. Value of ambulatory arterial stiffness index and 24-h pulse pressure to predict progression of albuminuria in elderly people with diabetes mellitus. Am J Hypertens 2007; 20: 493-500
28 Steigerwalt SP, Brar N, Dhungel A et al. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients. Transplant Proc 2009; 41: 4184-4187
29 Wright JR, Shurrab AE, Cooper A et al. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. Qjm 2009; 102: 695-704
30 Palmas W, Moran A, Pickering T et al. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 2006; 48: 301-308